Ampoule
Research use onlyBox Esafosfina 5g / 50mL
VAT included. Shipping calculated at checkout.
In stock
Secure delivery
Secure delivery with FedEx within 1–2 business days after payment confirmation
Payment methods
- Bank transfer
What is Esafosfina 5g/50ml?
Esafosfina 5g/50ml is an intravenous preparation containing phosphocreatine – a compound that occurs naturally in the human body and plays a key role in energy metabolism. Phosphocreatine is an essential component of the system for rapid energy production, which enables cells to maintain adequate adenosine triphosphate (ATP) levels during acute stress or physical exertion.
Thanks to its ability to serve as an energy reserve, phosphocreatine is actively involved in providing immediately available energy to muscle cells, nerve tissue and other energy-dependent systems.
Esafosfina 5g/50ml is used under medical supervision to support energy dynamics in the body, particularly in situations where cells have increased metabolic demands or where temporary disturbances in energy balance occur. The product is intended for intravenous use and ensures direct and rapid availability of phosphocreatine in the systemic circulation.
What are the benefits of Esafosfina 5g/50ml?
- Esafosfina 5g/50ml is a preparation that supports normal cellular energy metabolism and can be helpful in conditions associated with energy deficiency, metabolic impairment or increased physical strain. The main effects include:
- Improved cellular energy balance: phosphocreatine is a central component of ATP resynthesis and helps maintain normal energy activity in muscle and nerve cells.
- Support for muscle function: thanks to its role as a rapid source of energy, Esafosfina can support cellular processes in muscle tissue and help maintain muscle function during physical exertion.
- Support during increased energy demand: the preparation is used in protocols aimed at regeneration in cases of exhaustion, after intense exertion or with long-lasting physiological stress factors.
- Improved cardiac energetics: phosphocreatine plays an important role in the energy metabolism of the heart muscle. Esafosfina is used under medical supervision in conditions where the heart tissue has increased metabolic demands.
- Support for the nervous system: cells of the nerve tissue are highly dependent on sufficient energy reserves. Phosphocreatine helps maintain their optimal function and can be helpful in conditions associated with fatigue or neurological strain.
- Optimisation of metabolic processes: Esafosfina may play a role in maintaining metabolic stability, particularly under conditions of stress, increased physical activity or metabolic disorders.
- Promotion of regeneration: as part of the energy recycling system, phosphocreatine supports regeneration and cellular metabolism after physical or physiological strain.
Correct use and dosage of Esafosfina 5g/50ml:
Esafosfina 5g/50ml is an intravenous therapy, which means that it is administered by infusion.
Correct dosage: as with all medical products, the dosage of Esafosfina 5g/50ml depends on individual needs. It is recommended to determine the dose according to personal parameters and the specific conditions of use.
Administration: as Esafosfina is an intravenous therapy, it is usually administered by infusion or injection. It should be administered exclusively by qualified medical professionals.
Monitoring of results: during the use of Esafosfina 5g/50ml, the patient's condition is monitored and attention is paid to possible changes. In the event of adverse reactions or if the expected results are not achieved, the dosage should be adjusted or use discontinued under the supervision of a qualified specialist.
Following instructions: Esafosfina 5g/50ml must be used exactly as instructed by the treating doctor. The dosage or method of administration must not be changed without the prior consent of a specialist.
Possible side effects of Esafosfina 5g/50ml:
Esafosfina is generally well tolerated when used in accordance with medical guidelines. Nevertheless – as with all intravenous preparations – certain reactions may occur. The most frequently reported include:
- Redness or burning at the infusion site
- Mild headache
- Temporary nervous symptoms such as restlessness or nervousness
- Slight changes in heart rhythm
- Feeling of tiredness or weakness
If unusual symptoms occur, a medical consultation is recommended. Controlling the dosage and infusion rate is important to avoid adverse reactions and to ensure safe and effective use.












